TY - JOUR
T1 - NCCN Task Force
T2 - Clinical utility of PET in a variety of tumor types
AU - Podoloff, Donald A.
AU - Ball, Douglas W.
AU - Ben-Josef, Edgar
AU - Benson, Al B.
AU - Cohen, Steven J.
AU - Coleman, R. Edward
AU - Delbeke, Dominique
AU - Ho, Maria
AU - Ilson, David H.
AU - Kalemkerian, Gregory P.
AU - Lee, Richard J.
AU - Loeffler, Jay S.
AU - Macapinlac, Homer A.
AU - Morgan, Robert J.
AU - Siegel, Barry Alan
AU - Singhal, Seema
AU - Tyler, Douglas S.
AU - Wong, Richard J.
PY - 2009/1/1
Y1 - 2009/1/1
N2 - Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments.
AB - Use of PET is widespread and increasing in the United States, mainly for oncologic applications. In November 2006, the National Comprehensive Cancer Network (NCCN) gathered a panel of experts to review the literature and develop clinical recommendations for using PET scans in lymphoma and non-small cell lung, breast, and colorectal cancers. However, because its use is not restricted to these diseases, and evidence is accumulating for its application in other types of cancers, NCCN convened a second meeting in December 2008 to expand on the initial report. A multidisciplinary panel met to discuss the current data on PET application for various tumor types, including genitourinary, gynecologic, pancreatic, hepatobiliary, thyroid, brain, small cell lung, gastric, and esophageal cancers, and sarcoma and myeloma. This report summarizes the proceedings of this meeting, including discussions of the background of PET, the role of PET in oncology, principles of PET use, emerging applications, and possible future developments.
KW - Biliary tract cancer
KW - Brain cancer
KW - Esophageal cancer
KW - Gastric cancer
KW - Genitourinary cancers
KW - Gynecological cancers
KW - Liver cancer
KW - Myeloma
KW - PET
KW - PET/CT
KW - Pancreatic cancer
KW - Sarcoma
KW - Small cell lung cancer
KW - Thyroid cancer
UR - http://www.scopus.com/inward/record.url?scp=67650436288&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=67650436288&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2009.0075
DO - 10.6004/jnccn.2009.0075
M3 - Review article
C2 - 19555588
AN - SCOPUS:67650436288
SN - 1540-1405
VL - 7
SP - S1-S25
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - SUPPL. 2
ER -